Prevalence of medication-related osteonecrosis of the jaw (MRONJ) in breast cancer patients receiving low-dose bone modifying agents for cancer treatment-induced bone loss (CTIBL): need for further data
0 citationsSupportive Care in Cancer
Vittorio Fusco
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
165Publications signalées
3221Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Bone health and treatmentsBone and Joint DiseasesCancer Diagnosis and TreatmentOral health in cancer treatmentBone Tumor Diagnosis and Treatments
Publications récentes
Italian regional data and oropharyngeal adverse events to drugs and vaccines: insights from a 3-year spontaneous reporting (2022–2024)
Liberata Sportiello, Mario Gaio, Alessia Zinzi, Gaetano La Mantia et autres
0 citationsPharmacological Reports
Timing, Geography, and Pragmatic Risk Reduction in Prevention of Medication-Related Osteonecrosis of the Jaw During Low-Dose BMA Therapy
Giuseppina Campisi, Martina Coppini, Vittorio Fusco, Alberto Bedogni et autres
0 citationsOral
Possible Contribution of Oral Microbiota in the Osteonecrosis of the Jaw Induced by Zoledronate or Denosumab: A Preliminary Study
Francesco Erovigni, Alessandra Manca, Virginia Moscone, Miriam Antonucci et autres
1 citationBiomedicines
Medication-related osteonecrosis of the jaw primary prevention: multidomain long-term intervention versus pre-bisphosphonate treatment standalone dental intervention. A retrospective multi-center comparative cohort study
Rodolfo Mauceri, Gaetano La Mantia, Olga Di Fede, Vittorio Fusco et autres
0 citationsSupportive Care in Cancer
Psychosocial impact of COVID-19 pandemic on patients with solid malignancies and bone metastases (PsyCO-B): a multicentre prospective observational study
Paolo Taurisano, Ester Cornacchia, Maria Fara De, Vittorio Fusco et autres
0 citationsJournal of bone oncology
Prevention of medication-related osteonecrosis of the jaws (MRONJ): updated recommendations for dental hygienists from the Italian consensus conference
Rodolfo Mauceri, Martina Coppini, Rita Coniglio, Antonella Abbinante et autres
0 citationsOral Hygiene Journal
Palbociclib and risk of medication related osteonecrosis of the jaw (MRONJ): another word of cautiousness
Vittorio Fusco, Alberto Bedogni, Rodolfo Mauceri, G M Bo et autres
0 citationsOral Surgery Oral Medicine Oral Pathology and Oral Radiology
Corrigendum to “Evaluation of a context-aware chatbot using retrieval-augmented generation for answering clinical questions on medication-related osteonecrosis of the jaw” [J. Craniomaxillofac. Surg. 53 (2025) 355–360]
David Steybe, Philipp Poxleitner, Suad Aljohani, Bente Brokstad Herlofson et autres
1 citationJournal of Cranio-Maxillofacial Surgery
Oral health status and quality of life in female patients receiving low dose bone-modifying agents for cancer treatment-induced bone loss: a single-center exploratory study
Rodolfo Mauceri, Martina Coppini, Sara Maria Marchese, Nicola Mauceri et autres
1 citationFrontiers in Oral Health
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives
Riccardo Gerosa, Michela Cinquini, Massimo Di Maïo, Federica Miglietta et autres
2 citationsTumori Journal
Trastuzumab and other new drugs potentially involved in medication-related osteonecrosis of the jaws (MRONJ): need of rules?
Vittorio Fusco, Alberto Bedogni, Rodolfo Mauceri, Giuseppina Campisi
1 citationOral Surgery Oral Medicine Oral Pathology and Oral Radiology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.